Literature DB >> 16353851

Mapping therapy for sentence production impairments in nonfluent aphasia.

Elizabeth Rochon1, Laura Laird, Arpita Bose, Joanne Scofield.   

Abstract

This study investigated a new treatment in which sentence production abilities were trained in a small group of individuals and nonfluent aphasia. It was based upon a mapping therapy approach which holds that sentence production and comprehension impairments are due to difficulties in mapping between the meaning form (thematic roles) and the syntactic form of sentences. We trained production of both canonical and noncanonical reversible sentences. Three patients received treatment and two served as control participants. Patients who received treatment demonstrated acquisition of all trained sentence structures. They also demonstrated across-task generalisation of treated and some untreated sentence structures on two tasks of constrained sentence production, and showed some improvements on a narrative task. One control participant improved on some of these measures and the other did not. There was no noted improvement in sentence comprehension abilities following treatment. Results are discussed with reference to the heterogeneity of underlying impairments in sentence production impairments in nonfluent patients, and the possible mechanisms by which improvement in sentence production might have been achieved in treatment.

Entities:  

Mesh:

Year:  2005        PMID: 16353851     DOI: 10.1080/09602010343000327

Source DB:  PubMed          Journal:  Neuropsychol Rehabil        ISSN: 0960-2011            Impact factor:   2.868


  16 in total

1.  Sentactics®: Computer-Automated Treatment of Underlying Forms.

Authors:  Cynthia K Thompson; Jungwon Janet Choy; Audrey Holland; Ronald Cole
Journal:  Aphasiology       Date:  2010-10       Impact factor: 2.773

2.  Verb and sentence production and comprehension in aphasia: Northwestern Assessment of Verbs and Sentences (NAVS).

Authors:  Soojin Cho-Reyes; Cynthia K Thompson
Journal:  Aphasiology       Date:  2012       Impact factor: 2.773

3.  Grammatical Planning Units During Real-Time Sentence Production in Speakers With Agrammatic Aphasia and Healthy Speakers.

Authors:  Jiyeon Lee; Masaya Yoshida; Cynthia K Thompson
Journal:  J Speech Lang Hear Res       Date:  2015-08       Impact factor: 2.297

4.  Evaluating Treatment and Generalization Patterns of Two Theoretically Motivated Sentence Comprehension Therapies.

Authors:  Carrie A Des Roches; Sofia Vallila-Rohter; Sarah Villard; Yorghos Tripodis; David Caplan; Swathi Kiran
Journal:  Am J Speech Lang Pathol       Date:  2016-12-01       Impact factor: 2.408

5.  Effects of Verb Overlap on Structural Priming in Dialogue: Implications for Syntactic Learning in Aphasia.

Authors:  Grace Man; Sarah Meehan; Nadine Martin; Holly Branigan; Jiyeon Lee
Journal:  J Speech Lang Hear Res       Date:  2019-05-20       Impact factor: 2.297

6.  Grammatical Encoding and Learning in Agrammatic Aphasia: Evidence from Structural Priming.

Authors:  Soojin Cho-Reyes; Jennifer E Mack; Cynthia K Thompson
Journal:  J Mem Lang       Date:  2016-03-21       Impact factor: 3.059

7.  Semantic memory for objects, actions, and events: A novel test of event-related conceptual semantic knowledge.

Authors:  Haley C Dresang; Michael Walsh Dickey; Tessa C Warren
Journal:  Cogn Neuropsychol       Date:  2019-08-26       Impact factor: 2.468

8.  Complexity in treatment of syntactic deficits.

Authors:  Cynthia K Thompson; Lewis P Shapiro
Journal:  Am J Speech Lang Pathol       Date:  2007-02       Impact factor: 2.408

9.  Assessing Syntactic Deficits in Chinese Broca's aphasia using the Northwestern Assessment of Verbs and Sentences-Chinese (NAVS-C).

Authors:  Honglei Wang; Cynthia K Thompson
Journal:  Aphasiology       Date:  2015-11-16       Impact factor: 2.773

10.  Phonological facilitation effects on naming latencies and viewing times during noun and verb naming in agrammatic and anomic aphasia.

Authors:  Jiyeon Lee; Cynthia K Thompson
Journal:  Aphasiology       Date:  2015       Impact factor: 2.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.